Experience In The Treatment Of Hepatitis B Virus Associated Aplastic Anemia Stated

Hepatitis B virus associated aplastic anemia is a rare clinical extrahepatic disease, its Western medicine pathogenesis mechanism is not very clear, the prognosis is relatively poor.This disease is no corresponding name in Chinese medicine, and can be attributed to "consumptive", "blood deficiency," "Blood" category in the view of clinical. In general , its etioloty and pathogenesis is complex, and its pathological nature belongs to deficiency or mixed by deficiency and excess or deficiency in inter and excess in appearance. Location of disease, mainly in the liver, spleen, kidney three dirty. It is easily leading to lack of blood ,blood stasis or blood regime's reckless in the reasons of kidney deficiency, yang deficiency in spleen and kidney, yin deficiency in kidney and liver. That causes anemia,bleeding and ecchymosis or petechia. In treatment mainly should be based on the kidney, taking into account the liver and spleen two dirty. Professor Lu Bingjiu is professional in regulating yin and yang, focusing on enhancing Qi-blood ,appling in warming spleen-kidney,nourishing liver-kidney, promoting blood circulation of the method used in the treatment of disease, access to good clinical efficacy. Because to its close relation to hepatitis B virus (HBV), it is often used to clearing away heat and detoxifying drugs to achieve the purpose of fighting the virus in clinical, but also combined with research results of hepatitis B virus associated aplastic anemia on modern medicine, using the method of traditional Chinese medicine and Western Medicine, combined with western medicine interferon, lamivudine and other anti-virus, which achieve a better efficacy in basis.